Hikal appoints Dr. Vadiraj Ekkundi as Head - R&D, Bangalore

Image
Announcement Corporate
Last Updated : Jan 21 2013 | 2:33 AM IST

Hikal Ltd., the preferred long-term outsourcing partner for leading global life sciences and specialty chemicals companies today announced the appointment of  Dr. Vadiraj Ekkundi as the Head of  its R&D facility in Bangalore.

Dr. Ekkundi comes with over 26 years of experience in the field of Research & Development activities. His experience encompasses a mix of scientific, technical as well as managerial roles. He has occupied various top level positions in leading multinational companies such as Hindustan Lever Limited, Wyeth Laboratories, Atul Products Limited, and Ciba group to name a few.

Dr. Ekkundi has done his MSc from Dharwad University and PhD from Indian Institute of Technology, Mumbai. He has also done his Post Doctoral Research from the Institute of Organic Chemistry, Braunschweig, Germany and the Boston College, USA.

"We are pleased to have Dr. Ekkundi join us. Dr Ekkundi’s expertise and strong leadership capabilities will add immense value to our R&D processes and business" said Mr. Jai Hiremath, Vice Chairman and Managing Director, Hikal.

The Hikal R&D Center in Bangalore provides process research of APIs, AIs and intermediates involving multi-step synthesis. It has a successful track record in developing non-infringing processes and scaling up from lab to kilo to commercialization

About Hikal Ltd.
Hikal is a reliable long-term outsourcing partner to companies in the Pharmaceuticals, Crop protection Products, and Specialty Chemicals industry. The company has been supplying key active ingredients (AI), API’s and intermediates, manufactured using stringent global quality standards, for its customers in the United States, Europe and Japan. Hikal’s advanced manufacturing facilities have been inspected and approved by leading global players in Crop protection and Pharmaceutical sectors. The crop protection facilities are located at Taloja and Mahad (Maharashtra). Hikal’s manufacturing activities are supported by state-of-the-art research centres and pilot plant facilities located at Bangalore and Taloja respectively. The API and pharmaceutical intermediates manufacturing facilities are situated in Jigani (Bangalore) and Panoli (Gujarat), respectively. Hikal has also commissioned Acoris Research Ltd., a state-of-the-art contract research facility at the International Biotech Park, Pune.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 09 2010 | 6:47 PM IST

Next Story